• 1
    Cairo MS, Bishop M. Tumour lysis syndrome: new therapeutic strategies and classification. Br J Haematol 2004;127:311.
  • 2
    Frei Er, Bentzel CJ, Rieselbach R, et al. Renal complications of neoplastic disease. J Chronic Dis 1963;16:757776.
  • 3
    Abu-Alfa AK, Younes A. Tumor lysis syndrome and acute kidney injury: Evaluation, prevention, and management. Am J Kidney Dis 2010;55:S1S13; quiz S14–S19.
  • 4
    Coiffier B, Altman A, Pui CH, et al. Guidelines for the management of pediatric and adult tumor lysis syndrome: An evidence-based review. J Clin Oncol 2008;26:27672778.
  • 5
    Cortes J, Moore JO, Maziarz RT, et al. Control of plasma uric acid in adults at risk for tumor Lysis syndrome: Efficacy and safety of rasburicase alone and rasburicase followed by allopurinol compared with allopurinol alone—Results of a multicenter phase III study. J Clin Oncol 2010;28:42074213.
  • 6
    Goldman SC, Holcenberg JS, Finklestein JZ, et al. A randomized comparison between rasburicase and allopurinol in children with lymphoma or leukemia at high risk for tumor lysis. Blood 2001;97:29983003.
  • 7
    Yubisui T, Takeshita M, Yoneyama Y. Reduction of methemoglobin through flavin at the physiological concentration by NADPH-flavin reductase of human erythrocytes. J Biochem 1980;87:17151720.
  • 8
    Ueng S. Rasburicase (Elitek): A novel agent for tumor lysis syndrome. Proc (Bayl Univ Med Cent) 2005;18:275279.
  • 9
    Bauters T, Mondelaers V, Robays H, et al. Methemoglobinemia and hemolytic anemia after rasburicase administration in a child with leukemia. Int J Clin Pharm 2011;33:5860.
  • 10
    Bhat P, Sisler I, Collier ABIII. Exchange transfusion as treatment for rasburicase induced methemoglobinemia in a glucose-6-phosphate dehydrogenase deficient patient. Pediatr Blood Cancer 2008;51:568.
  • 11
    Borinstein SC, Xu M, Hawkins DS. Methemoglobinemia and hemolytic anemia caused by rasburicase administration in a newly diagnosed child with Burkitt lymphoma/leukemia. Pediatr Blood Cancer 2008;50:189.
  • 12
    Browning LA, Kruse JA. Hemolysis and methemoglobinemia secondary to rasburicase administration. Ann Pharmacother 2005;39:19321935.
  • 13
    Kizer N, Martinez E, Powell M. Report of two cases of rasburicase-induced methemoglobinemia. Leuk Lymphoma 2006;47:26482650.
  • 14
    Kamat V. Pulse oximetry. Indian J Anaesth 2002;46:261268.
  • 15
    Rosen PJ, Johnson C, McGehee WG, et al. Failure of methylene blue treatment in toxic methemoglobinemia. Association with glucose-6-phosphate dehydrogenase deficiency. Ann Intern Med 1971;75:8386.
  • 16
    Dunne J, Caron A, Menu P, et al. Ascorbate removes key precursors to oxidative damage by cell-free haemoglobin in vitro and in vivo. Biochem J 2006;399:513524.